RE:RE:RE:RE:RE:RE:RE:Industry ComparisonBevcanna was listed June 25th 2019- (27months) this doesn't include the prep years of Nutrivida.
Molecule was listed Sept 17th 2020 - (12months)
Three months later 1st production run.
Twenty three months for Bevcanna 1st production run.
Molecule was 8 months from listing to first beverage sales.
Bevcanna is 27 months from listing and has not had first sale.
MLCL has had a peak MC of $13.5M and currently $7.1M
BEV has had a peak MC $249M and currently $54.8M
Molecule was three months from licence to market.
Bevcanna applied for licences in 2018 and never received their process licence until Feb 2021 and still have not received their sales licence. Why? Covid? Gov't agencies? BS
Bevcanna states they have not been affected by Covid 19
MLCL has diluted original shareholders by 10%
BEV has diluted original shareholders by 75%
Naturo has been in business for a decade (continues to loss money) and management thought buying it for $68M was a smart investment. Not to mention all the millions pissed away on other lost leaders. Pure Therapy is another lost leader that should be written off.
Bevcanna is lossing $5.4M per quarter
MLCL is lossing $1.2M per quarter
MLCL has a deficit of $6.5M
BEV has a deficit $42M
There is success available in cannabis beverages, but it's not even close yet.
Molecule is not the only cannabis competitor to Bevcanna.
Bevcanna lost $14M last year and is heading toward another $15M -$20M in losses this year.
How much product do you need to sell in order to dig out of that hole?
This is accounting not dreaming.